Healthcare provider profile · identity verified

Amy Christopherson Anderson, MD

Family Practice · CHISAGO CITY, MN · NPI 1881630549

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	580	152
Losartan Potassium	Losartan Potassium	432	115
Lisinopril	Lisinopril	431	116
Simvastatin	Simvastatin	421	116
Levothyroxine Sodium	Levothyroxine Sodium	409	100
Omeprazole	Omeprazole	368	105
Amlodipine Besylate	Amlodipine Besylate	329	90
Metoprolol Succinate	Metoprolol Succinate	283	76
Rosuvastatin Calcium	Rosuvastatin Calcium	273	81
Gabapentin	Gabapentin	204	47
Metformin Hcl Er	Metformin Hcl	178	53
Hydrochlorothiazide	Hydrochlorothiazide	169	43
Sertraline Hcl	Sertraline Hcl	149	38
Atenolol	Atenolol	129	28
Furosemide	Furosemide	111	34
Albuterol Sulfate Hfa	Albuterol Sulfate	105	44
Tamsulosin Hcl	Tamsulosin Hcl	104	29
Estradiol	Estradiol	101	35
Metformin Hcl	Metformin Hcl	101	27
Metoprolol Tartrate	Metoprolol Tartrate	101	25
Pantoprazole Sodium	Pantoprazole Sodium	101	28
Alendronate Sodium	Alendronate Sodium	98	30
Jardiance	Empagliflozin	96	22
Glipizide Er	Glipizide	89	23
Fluticasone Propionate	Fluticasone Propionate	86	28
Escitalopram Oxalate	Escitalopram Oxalate	84	24
Citalopram Hbr	Citalopram Hydrobromide	75	19
Allopurinol	Allopurinol	74	21
Duloxetine Hcl	Duloxetine Hcl	74	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	73	13
Trazodone Hcl	Trazodone Hcl	72	20
Famotidine	Famotidine	69	22
Potassium Chloride	Potassium Chloride	68	20
Eliquis	Apixaban	66	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	14
Jantoven	Warfarin Sodium	62	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	16
Carvedilol	Carvedilol	59	18
Quetiapine Fumarate	Quetiapine Fumarate	58	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	15
Bupropion Xl	Bupropion Hcl	56	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	17
Trulicity	Dulaglutide	53	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	53	11
Hydroxyzine Hcl	Hydroxyzine Hcl	52	13
Pravastatin Sodium	Pravastatin Sodium	52	13
Warfarin Sodium	Warfarin Sodium	46	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	suppressed
Ozempic	Semaglutide	40	suppressed
Incruse Ellipta	Umeclidinium Bromide	39	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Montelukast Sodium	Montelukast Sodium	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	11
Finasteride	Finasteride	36	12
Oxycodone Hcl	Oxycodone Hcl	36	11
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Methocarbamol	Methocarbamol	32	17
Prednisone	Prednisone	31	16
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Baclofen	Baclofen	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Clobetasol Propionate	Clobetasol Propionate	29	14
Tramadol Hcl	Tramadol Hcl	29	12
Glimepiride	Glimepiride	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	19
Cefdinir	Cefdinir	26	19
Arnuity Ellipta	Fluticasone Furoate	25	suppressed
Nystatin	Nystatin	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Digoxin	Digoxin	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	20
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Naproxen	Naproxen	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Tresiba Flextouch U-200	Insulin Degludec	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	13
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Lactulose	Lactulose	20	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Propranolol Hcl	Propranolol Hcl	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Single Use Swab	Alcohol Antiseptic Pads	17	suppressed
Ultiguard Safepack-Pen Needle	Pen Needle, Diabetic,disp Unit	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	15
Ezetimibe	Ezetimibe	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Valsartan	Valsartan	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Azithromycin	Azithromycin	13	13
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Metolazone	Metolazone	13	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	13	suppressed
Velivet	Desogestrel-Ethinyl Estradiol	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Linzess	Linaclotide	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Byetta	Exenatide	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error